Clinical features of gout in a cohort of Italian patients;Caratteristiche cliniche della gotta in una coorte di pazienti Italiani

Reumatismo

Volumn 61, Issue 1, 2009, Pages 41-47

  Zampogna, G ^a   Andracco, R ^a   Parodi, M ^a   Cimmino, Marco A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Comorbidity; Gout; Gouty arthritis; Seasonality

Indexed keywords

ALLOPURINOL; COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT; URATE; ANTIGOUT AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DRUG RESPONSE; DRUG USE; FAMILY HISTORY; FEMALE; GOUT; HAND JOINT; HUMAN; HYPERURICEMIA; ITALY; JOINT ASPIRATION; MAJOR CLINICAL STUDY; MALE; METATARSOPHALANGEAL JOINT; MONARTHRITIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEASONAL VARIATION; URIC ACID BLOOD LEVEL; AGE; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; EVALUATION; IN VITRO STUDY; MIDDLE AGED; SEASON; SEX DIFFERENCE; STATISTICAL ANALYSIS; TIME;

ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, GOUTY; COHORT STUDIES; COLCHICINE; DATA INTERPRETATION, STATISTICAL; FEMALE; GOUT; GOUT SUPPRESSANTS; HUMANS; ITALY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEASONS; SEX FACTORS; TIME FACTORS;

EID: 66149117497     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Salaffi F, De Angelis R, Grassi W. MArche Pain Prevalence INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005; 23: 819-28.
2. Salvarani C, Lo Scocco G, Macchioni P, Cremonesi T, Rossi F, Mantovani W, et al. Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 1995; 22: 1499-503.
3. Schapira D, Stahl S, Izhak OB, Balbir-Gurman A, Nahir AM. Chronic tophaceous gouty arthritis mimicking rheumatoid arthritis. Semin Arthritis Rheum 1999; 29: 56-63.
4. Petrilli V, Dostert C, Muruve DA, Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 2007; 19: 615-22.
5. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-41.
6. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007, 9: R28.
7. Becker MA, Schumacher HR Jr, Wortmann RL, Mac-Donald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 2450-61.
8. Ganson NJ, Kelly SJ, Scarlett E, Sundy JS, Hershfield MS. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PE-Gylated urate oxidase. Arthritis Res Ther 2006; 8: R12.
9. Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P, et al. EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1301-11.
10. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987; 82: 421-26.
11. Hunter DJ, York M, Chaisson CE, Woods R, Niu J, Zhang Y. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol. 2006; 33: 1341-5.
12. Grodzicki T, Palmer A, Bulpitt CJ, for the General Practice Hypertension Study Group. Incidence of diabetes and gout in hypertensive patients during 8 years of follow-up. J Hum Hypertens 1997; 11: 583-5.
13. Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC. Incidence and risk factors for gout in white men. JAMA. 1991; 266: 3004-7.
14. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
15. Rothschild BM, Pingitore C, Eaton M. Dactylitis: implications for clinical practice. Semin Arthritis Rheum 1998; 28: 41-7.
16. Roddy E, Zhang W, Doherty M. Gout and nodal osteoarthritis: a case-control study. Rheumatology (Oxford) 2008; 47: 732-3.
17. Schlesinger N, Gowin KM, Baker DG, Beutler AM, Hoffman BI, Schumacher HR, Jr. Acute gouty arthritis is seasonal. J Rheumatol 1998; 25: 342-4.
18. Arber N, Vaturi M, Schapiro JM, Jelin N, Weinberger A. Effect of weather conditions on acute gouty arthritis. Scand J Rheumatol 1994; 23: 22-4.
19. Punzi L, Salvati GP, Gambari PF. Seasonal variations in the frequency and synovial fluid inflammation in acute gout and pseudogout. J Rheumatol 1999; 26: 1642.
20. Gallerani M, Govoni M, Mucinelli M, Bigoni M, Trotta F, Manfredini R. Seasonal variation in the onset of acute microcrystalline arthritis. Rheumatology (Oxford). 1999; 38: 1003-6.
21. Nuki G. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep 2008; 10: 218-27.
22. Becker MA, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin North Am 2006; 32: 275-93, v-vi.
23. Singh JA, Strand V. Gout is associated with more comorbidities, poorer health related quality of life and higher health care utilization in US veterans. Ann Rheum Dis 2008; 67: 1310-6.
24. Pascual E, Doherty M. Aspiration of normal or asymptomatic pathological joints for diagnosis and research - indications, technique and success rate. Ann Rheum Dis 2009; 68: 3-7.